Pharma Sector Shows Wide Stock Performance Variation in 2025

Pharmaceutical stock performance varied widely in 2025, per a blog analysis. No specific figures, tickers, or drivers are reported in the source snippet. Relevance to radiology practice is unclear.

• Source is a blog post (Reza Zahiri via Substack); no methodology, data, or specific numbers are provided in the available snippet.
• Content covers pharmaceutical equities broadly — no imaging, device, or radiology-specific angle is identified from the snippet.
• Limitation: Unverified blog source with no peer review, no sample data, and no radiology relevance established.

RadPigeon summaries are original and for information only. They are not clinical advice.